CSI Market
Sign In | Register

Biorestorative Therapies Inc (BRTX) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access BRTX Annual Cash Flow →
From Biorestorative Therapies Inc through Mar 31 2025, changes in Mar 31 2026's operating cash flow provide insight into underlying business performance trends.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Mar 31 2026)
3 Months 		(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Operating Activities
Income-2.15
Depreciation & amortization0.05
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation0.29
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.00
Common Stock And Warrants Issued To Convert Notes Payable And Accrued Interest-
Conversion Of Notes Payable And Accrued Interest In To Common Stock-
Gain Loss Related To Settlement Of Note And Payables-
Conversion Of Notes Payable And Accruedinterest In To Common Stock-
Warrant Modification Expense-
Derivative Gain Loss On Derivative Net-1.22
Share Based Compensation Options-
Share Based Compensation Restricted Stock Award-
Gain On Ppp Loan Forgiveness-
Marketable Securities Unrealized Gain Loss-
Interest And Dividend Income Operating-0.01
Noncash Lease Expense-
Increase Decrease In Operating Lease Liability-
Derivative Loss On Derivative-
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable0.00
Increase (Decrease) in Accounts Payable-0.68
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities-0.06
Increase (Decrease) in Security Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-0.03
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities-3.81
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Marketable Securities1.04
Payments to Acquire Marketable Securities-0.07
Real Estate Investments0.00
Payments To License Maintenance Costs-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.97
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock-0.56
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock5.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Proceeds From Issuance Of Common Stock And Warrants Net-
Repayments Of Notes Payable Prepayment Premiums-
Payments On Notes Payable Prepayment Premiums-
Proceeds From Ppp Loan-
Payments For Proceeds From Deferred Offering Costs-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities4.44
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-3.81
Total Cash Flow1.60
4 historic quarters locked

Sign in to unlock the full Biorestorative Therapies Inc cash flow history.

Sign In Create Free Account

About Biorestorative Therapies Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20260331)
  • Filed with the SEC: May 14, 2026
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001493152-26-023126

Figures are derived from filed reports and may be restated. Historical data is subject to revision.